Cell Therapy

News

FDA sets date for Adaptimmune’s sarcoma drug verdict

The FDA is due to decide by 4th August whether to approve Adaptimmune’s engineered T-cell therapy for advanced synovial sarcoma, afamitresgene autoleucel (afami-cel), afte

News

JPM: Precision Bio continues offload of CAR-T rights

Precision BioSciences has agreed to a second licensing deal for its ‘off-the-shelf’ CAR-T therapy azer-cel, as it switches focus to developing in vivo applications of its

News

AZ makes another cell therapy play with $1.2bn Gracell buy

AstraZeneca has lined up a $1.2 billion takeover deal for Chinese biotech Gracell Biotechnologies, bolting a series of cell therapies for cancer and autoimmune diseases on

Market Access

Why the Novo Nordisk Foundation is betting big on stem cells

One area where the Novo Nordisk Foundation has invested quite heavily is in cell therapy, especially stem cell research.

R&D

How birth tissue donations are fuelling the cell therapy rev...

As the burgeoning field of cell therapy evolves, so do the practices around obtaining the raw biological material needed to create these life-changing treatments.

News

Cellectis rockets on gene-editing alliance with AstraZeneca

Shares in Cellectis shot up this morning after the French biotech revealed a wide-ranging alliance with AstraZeneca, which includes $245 million in near-term financial com

FDA sets date for Adaptimmune’s sarcoma drug verdict

JPM: Precision Bio continues offload of CAR-T rights

AZ makes another cell therapy play with $1.2bn Gracell buy

Why the Novo Nordisk Foundation is betting big on stem cells

How birth tissue donations are fuelling the cell therapy rev...

Cellectis rockets on gene-editing alliance with AstraZeneca

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

Cell Therapy

Editor's Picks